Bioxodes Raises €2.7 Million in Series A Extension Funding Round
Bioxodes, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases, raised €2.7 million from existing investors … Read more…